Literature DB >> 1357668

Homology of a vesicular amine transporter to a gene conferring resistance to 1-methyl-4-phenylpyridinium.

Y Stern-Bach1, J N Keen, M Bejerano, S Steiner-Mordoch, M Wallach, J B Findlay, S Schuldiner.   

Abstract

The vesicular amine transporter (VAT) catalyzes transport and storage of catechol and indolamines into subcellular organelles in a wide variety of cells. It plays a central role in neurotransmission and is the primary target for several pharmacological agents. One of the drugs, reserpine, binds very tightly to the transporter and remains bound even after solubilization, a finding that has proven useful for purification of the transporter from bovine adrenal medulla in a fully functional state. The sequences of 26 N-terminal amino acids and of an additional 7-amino acid internal peptide are presented. Antibodies against a synthetic peptide based on the above sequences immunoprecipitate the transporter, confirming the conclusion that the peptide sequence is derived from bovine VAT. To our knowledge, documentation of sequences of vesicular neurotransmitter transporters has not been presented previously. In addition, the sequences obtained are highly homologous to the predicted sequence of a protein from PC12 cells that confers to Chinese hamster ovary cells resistance to 1-methyl-4-phenylpyridinium (MPP+), an agent that causes parkinsonism in model systems, confirming the hypothesis that the protein conferring resistance to MPP+ is a VAT.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357668      PMCID: PMC50206          DOI: 10.1073/pnas.89.20.9730

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Uptake of catecholamines by a particulate fraction of the adrenal medulla.

Authors:  N KIRSHNER
Journal:  J Biol Chem       Date:  1962-07       Impact factor: 5.157

2.  Identification and purification of a functional amine transporter from bovine chromaffin granules.

Authors:  Y Stern-Bach; N Greenberg-Ofrath; I Flechner; S Schuldiner
Journal:  J Biol Chem       Date:  1990-03-05       Impact factor: 5.157

Review 3.  Vacuolar proton pumps.

Authors:  D K Stone; B P Crider; T C Südhof; X S Xie
Journal:  J Bioenerg Biomembr       Date:  1989-10       Impact factor: 2.945

4.  Role of a transmembrane pH gradient in epinephrine transport by chromaffin granule membrane vesicles.

Authors:  S Schuldiner; H Fishkes; B I Kanner
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

5.  Characterization of monoclonal antibodies against Chlamydomonas flagellar dyneins by high-resolution protein blotting.

Authors:  S M King; T Otter; G B Witman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

Review 6.  Mechanism of transport and storage of neurotransmitters.

Authors:  B I Kanner; S Schuldiner
Journal:  CRC Crit Rev Biochem       Date:  1987

Review 7.  The biological fate of reserpine.

Authors:  R E Stitzel
Journal:  Pharmacol Rev       Date:  1976-09       Impact factor: 25.468

8.  Reserpine binding to bovine chromaffin granule membranes. Characterization and comparison with dihydrotetrabenazine binding.

Authors:  D Scherman; J P Henry
Journal:  Mol Pharmacol       Date:  1984-01       Impact factor: 4.436

9.  Characterization and purification of the monoamine transporter of bovine chromaffin granules.

Authors:  M F Isambert; B Gasnier; D Botton; J P Henry
Journal:  Biochemistry       Date:  1992-02-25       Impact factor: 3.162

10.  Energy-driven uptake of the neurotoxin 1-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter.

Authors:  A J Daniels; J F Reinhard
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

View more
  7 in total

1.  Selective neurotoxins, chemical tools to probe the mind: the first thirty years and beyond.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

Review 2.  Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse.

Authors:  Peter A Crooks; Guangrong Zheng; Ashish P Vartak; John P Culver; Fang Zheng; David B Horton; Linda P Dwoskin
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

3.  The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei.

Authors:  M J Nirenberg; Y Liu; D Peter; R H Edwards; V M Pickel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

4.  The heterotrimeric G protein Go2 regulates catecholamine uptake by secretory vesicles.

Authors:  G Ahnert-Hilger; B Nürnberg; T Exner; T Schäfer; R Jahn
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

5.  Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine.

Authors:  M J Nirenberg; J Chan; Y Liu; R H Edwards; V M Pickel
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

6.  Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.

Authors:  J D Erickson; M K Schafer; T I Bonner; L E Eiden; E Weihe
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 7.  Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.

Authors:  Thomas S Guillot; Gary W Miller
Journal:  Mol Neurobiol       Date:  2009-03-04       Impact factor: 5.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.